Literature DB >> 3710056

Clinicopathological study of sclerotherapy of esophageal varices. I. A review of 26 autopsy cases.

S Matsumoto.   

Abstract

Twenty six autopsy cases treated by endoscopic injection sclerotherapy (an intravariceal injection method) using ethanolamine oleate were examined for morphological changes in relation to the time intervals following injection. Red thrombi obliterated in the varices were recognized within 20 days of the treatment, and after a month, organization and shrinkage had occurred. Neutrophil infiltration of the esophageal wall was present within four days, and hemorrhage within six days. Edema and necrosis, the degree of which tended to decrease gradually with time, were observed within 20 days. Granulation tissue was first seen 10 days after treatment, followed by increased transformation of fibroblasts into fibrocytes. After two and a half months, an almost cell-free fibrotic-sclerotic stroma was recognized. The results obtained suggest that this treatment creates not only thrombi in vessels which are at risk of bleeding but also fibrosis which prevents rupture of the varices when a sclerosant is leaked or injected into the interstitial tissue. The results might furthermore serve as a basis for a prospective morphological study of patients with varices treated with ethanolamine oleate.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3710056     DOI: 10.1007/bf02774826

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  16 in total

1.  Blood vessel binding of free fatty acid and venous thrombosis.

Authors:  W L Bloom
Journal:  Metabolism       Date:  1967-09       Impact factor: 8.694

2.  A review of 15 years' experience in the use of sclerotherapy in the control of acute haemorrhage from oesophageal varices.

Authors:  G W Johnston; H W Rodgers
Journal:  Br J Surg       Date:  1973-10       Impact factor: 6.939

3.  Technical aspects of injection sclerotherapy of acute oesophageal variceal haemorrhage as seen by radiography.

Authors:  M S Barsoum; N Y Khattar; M Z Risk-Allah
Journal:  Br J Surg       Date:  1978-08       Impact factor: 6.939

4.  Morphological changes in the terminal oesophagus with varices, following sclerosis of the wall.

Authors:  B Helpap; L Bollweg
Journal:  Endoscopy       Date:  1981-11       Impact factor: 10.093

5.  Increased long-term survival in variceal haemorrhage using injection sclerotherapy. Results of a controlled trial.

Authors:  B R MacDougall; D Westaby; A Theodossi; J L Dawson; R Williams
Journal:  Lancet       Date:  1982-01-16       Impact factor: 79.321

6.  Oesophageal varices treated by sclerotherapy: a histopathological study.

Authors:  D M Evans; D B Jones; B K Cleary; P M Smith
Journal:  Gut       Date:  1982-07       Impact factor: 23.059

7.  Injection sclerotherapy of esophageal varices for patients undergoing emergency and elective surgery.

Authors:  Y Takase; A Ozaki; K Orii; K Nagoshi; T Okamura; Y Iwasaki
Journal:  Surgery       Date:  1982-09       Impact factor: 3.982

8.  Endoscopic sclerotherapy for bleeding esophageal varices: effects and complications.

Authors:  S J Ayres; J S Goff; G H Warren
Journal:  Ann Intern Med       Date:  1983-06       Impact factor: 25.391

9.  Oesophageal stricture and dysphagia after endoscopic sclerotherapy for bleeding varices.

Authors:  T Sørensen; F Burcharth; M L Pedersen; F Findahl
Journal:  Gut       Date:  1984-05       Impact factor: 23.059

10.  Pathological studies on esophageal varices treated with injection sclerotherapy.

Authors:  Y Takase; M Kikuchi; A Ozaki; S Shibuya; Y Iwasaki
Journal:  Jpn J Surg       Date:  1985-01
View more
  2 in total

1.  Extent of thrombi following sclerotherapy of esophageal varices.

Authors:  S Matsumoto; M Arakawa; A Toyonaga
Journal:  Gastroenterol Jpn       Date:  1986-10

2.  Prophylactic versus emergency sclerotherapy of large esophageal varices prior to liver transplantation.

Authors:  D H Van Thiel; V J Dindzans; R R Schade; M Rabinovitz; J S Gavaler
Journal:  Dig Dis Sci       Date:  1993-08       Impact factor: 3.199

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.